Business
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates
SHANGHAI & CAMBRIDGE, Mass., May 08, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the first quarter of 2025, along with recent product highlights and corporate updates.
About this update from Zai Lab Ltd.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":224,"url":"https://media.zenfs.com/en/business-wire.com/6822772cb5e1e3c8ddb21df670a3a33e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Hlz9WoHBnwqXK6oRGN8v2w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ0ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6822772cb5e1e3c8ddb21df670a3a33e","width":480,"height":224}},"lazy":false},{"type":"text","content":"– Total revenues grew 22% y-o-y to $106.5 million for the first quarter of 2025; reaffirming full-year 2025 revenue guidance of $560 million to $590 million","length":156,"tagName":"p"},{"type":"text","content":"– Operating loss improved significantly, declining 20% year-over-year to $56.3 million for the first quarter of 2025, and 25% to $37.1 million on an adjusted basis1; on track to achieve profitability1 in the fourth quarter of 2025","length":230,"tagName":"p"},{"type":"text","content":"– ZL-1310 (DLL3 ADC) is advancing rapidly, with upcoming ASCO 2025 data presentation in ES-SCLC; initiation of registrational study in ES-SCLC expected in the second half of 2025","length":178,"tagName":"p"},{"type":"text","content":"– AACR 2025 presentations of ZL-6201 (LRRC15 ADC) and ZL-1222 (PD-1/IL-12) underscore the promising potential of Zai Lab’s internally developed next-generation oncology therapies","length":178,"tagName":"p"},{"type":"text","content":"– Strong balance sheet with a cash position2 of $857.3 million as of March 31, 2025, compared to $879.7 million as of December 31, 2024","length":135,"tagName":"p"},{"type":"text","content":"Conference call and webcast today, May 8, 2025, at 8:00 a.m. ET (8:00 p.m. HKT)","length":79,"tagName":"p","attribs":{}},{"type":"text","content":"SHANGHAI & CAMBRIDGE, Mass., May 08, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the first quarter of 2025, along with recent product highlights and corporate updates.","length":231,"tagName":"p"},{"type":"text","content":""In the first quarter, we continued to advance both our global pipeline and commercial business," said Dr. Samantha Du, Founder, Chairperson, and CEO of Zai Lab. "We are rapidly expanding our global portfolio, having recently presented promising data for two...